PuriCore, the contamination control company, says the Biotechnology and Biological Sciences Research Council has granted the University of Oxford half a million pounds to research its ActiVita product, a fungicidal solution designed to protect crops from infections.
The three-year grant will fund research focused on exploring the mode of action of the ActiVita solution on fungi that devastate major food crops, including wheat, rice and maize.
Christopher Wightman, Executive Chairman of PuriCore, said: "The annual fungicide market is valued at approximately $12bn worldwide, yet substantial crop loss due to pathogen infestation continues to be a major issue ... we believe that ActiVita could represent a significant scientific advancement in protecting important food crops from plant disease."
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The person who will lead the research, Sarah Gurr, Professor of Molecular Plant Pathology, at the University of Oxford, says the problem is that "extant fungal strains, and now, even more aggressive emerging strains, pose a serious threat to our annual harvests and so challenge global food security."
The figures back up her assertion; 10-30% of harvestable rice is lost to the "rice blast" fungus; 10-70% of harvestable wheat is lost due to stem rust infection; and 2-20% of harvestable maize is lost to the worryingly named "corn smut".
Shares in PuriCore had risen 8.5% by 11:09am. Over the last 12 months the stock is up 14%.
BS
-
Ofgem proposes new energy tariffs with low or no standing changesStanding charges have invited public backlash as households battle high energy bills
-
Google shares bounce on Gemini 2.0 launchGoogle has launched the latest version of its Gemini AI platform, and markets have responded positively. Is it time to buy Google shares?
